Market cap
$1,190 Mln
Revenue (TTM)
$1,041 Mln
P/E Ratio
--
P/B Ratio
9.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 2.97 | 5.77 | -7.10 | 9.63 | 11.48 |
| EBIT | 0.22 | 67.01 | 72.91 | 20.65 | -223.27 |
| Net Profit | -3.80 | 59.60 | 69.18 | 21.90 | -257.39 |
| EPS | -3.80 | 60.40 | 69.94 | 20.11 | -260.88 |
| Book Value | -- | -- | -42.63 | -30.63 | -16.37 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -19.30 | -13.21 | -5.07 | -18.96 | -10.56 |
| Net Margin
| -- | -4.79 | -6.08 | -- | -- |
| Return on equity
| -63.42 | -41.61 | -44.34 | -97.88 | -33.30 |
| Return on Capital
| -23.92 | -16.24 | -- | -30.64 | -13.10 |
| Return on Assets
| -18.12 | -12.42 | -5.00 | -22.15 | -10.00 |
| Debt to Equity (x)
| -- | -- | 4.62 | 2.86 | 1.80 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
ROE
-44.34
Lower than Peers by 49.26
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
-44.34
|
-97.88
|
-33.30
|
-59.08
|
-21.67
|
3.89
|
|||||
|
Peer Median
|
4.91
|
--
|
--
|
--
|
--
|
--
|
ROA
-5.00
Lower than Peers by 7.42
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
-5.00
|
-22.15
|
-10.00
|
-22.20
|
-9.66
|
1.92
|
|||||
|
Peer Median
|
2.42
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-5.07
Lower than Peers by 13.52
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
-5.07
|
-18.96
|
-10.56
|
-28.38
|
-11.05
|
2.88
|
|||||
|
Peer Median
|
8.45
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-6.08
Lower than Peers by 10.53
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
-6.08
|
-20.17
|
-10.21
|
-29.77
|
-11.81
|
2.24
|
|||||
|
Peer Median
|
4.45
|
--
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
Revenue Growth
-7.10
Lower than Peers by 15.59
Year on year growth in net sales
EBIT Growth
72.91
Higher than Peers by 62.48
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
72.91
|
-93.75
|
53.21
|
-139.64
|
-538.01
|
354.04
|
|||||
|
Peer Median
|
10.43
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
69.18
Higher than Peers by 55.51
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
69.18
|
-113.18
|
56.86
|
-135.33
|
-707.70
|
145.27
|
|||||
|
Peer Median
|
13.67
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
69.94
Higher than Peers by 48.79
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
69.94
|
-1.07
|
0.57
|
-1.32
|
-7.22
|
1.45
|
|||||
|
Peer Median
|
21.15
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
-4.10
Lower than Peers by 10.64
Year on year growth in book value per share
Solvency
Debt to Equity
4.62
Higher than Peers by 4.22
Total debt / Net worth
Short term debt to equity ratio
0.16
--
(Short term borrowings / Net worth)
Current Ratio
3.18
Higher than Peers by 0.41
Current Assets / Current Liabilities and Provisions
Quick Ratio
2.65
Higher than Peers by 0.62
(Current Assets - Inventory) / Current Liabilities and Provisions
Interest Coverage
-6.42
Lower than Peers by 11.30
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
-6.42
|
-24.33
|
-13.39
|
-21.47
|
-14.26
|
3.35
|
|||||
|
Peer Median
|
4.88
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
15.56
Lower than Peers by 0.87
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
15.56
|
16.31
|
12.19
|
14.12
|
14.32
|
15.75
|
|||||
|
Peer Median
|
16.43
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.82
Higher than Peers by 0.31
Sales / Average Total Assets
Receivable days
--
--
Average Debtors / Sales * 365
Inventory Days
--
--
Average Inventory / Sales * 365
Payable days
--
--
Average Creditors / Cost of goods sold * 365
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
--
|
-7.30
|
-24.82
|
-8.69
|
-30.59
|
637.50
|
|||||
|
Peer Median
|
43.09
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
9.77
Higher than Peers by 6.17
Current share price divided by book value per share in the latest financial year
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
EV/EBITDA
345.75
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
Market Cap
1,190
Higher than Peers by 655
Current Share price multiplied by latest total number of shares outstanding